213 related articles for article (PubMed ID: 36793057)
1. Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma.
Zhang L; Chen C; Chai D; Li C; Qiu Z; Kuang T; Liu L; Deng W; Wang W
J Transl Med; 2023 Feb; 21(1):126. PubMed ID: 36793057
[TBL] [Abstract][Full Text] [Related]
2. Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma.
Zhang L; Chen C; Chai D; Kuang T; Deng W; Wang W
Front Microbiol; 2022; 13():1090392. PubMed ID: 36687597
[TBL] [Abstract][Full Text] [Related]
3. The gut mycobiome of the Human Microbiome Project healthy cohort.
Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
[TBL] [Abstract][Full Text] [Related]
4. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma.
Lapidot Y; Amir A; Nosenko R; Uzan-Yulzari A; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Safran M; Ben-Ari Z
mSystems; 2020 Jun; 5(3):. PubMed ID: 32546668
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
[TBL] [Abstract][Full Text] [Related]
7. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease.
Jiang S; Xu L; Chen Y; Shu Z; Lv L; Zhao Y; Bi K; Yang S; Wang Q; Li L
Sci China Life Sci; 2024 Jun; 67(6):1183-1198. PubMed ID: 38413553
[TBL] [Abstract][Full Text] [Related]
9. Host Factors Associated with Gut Mycobiome Structure.
Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
[TBL] [Abstract][Full Text] [Related]
10. Expansion of Opportunistic Enteric Fungal Pathogens and Occurrence of Gut Inflammation in Human Liver Echinococcosis.
Wang Y; Guo A; Liu Z; Zou Y; Zhu W; Wu S; Zhang S; Guo X; Zhang S; Pu L; Zhu XQ; Zhu G; Cai X; Wang S
Microbiol Spectr; 2022 Oct; 10(5):e0145322. PubMed ID: 36098525
[TBL] [Abstract][Full Text] [Related]
11. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
[TBL] [Abstract][Full Text] [Related]
13. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
[TBL] [Abstract][Full Text] [Related]
14.
Zhong M; Xiong Y; Zhao J; Gao Z; Ma J; Wu Z; Song Y; Hong X
Theranostics; 2021; 11(10):4945-4956. PubMed ID: 33754037
[No Abstract] [Full Text] [Related]
15. Gut mycobiota changes in liver diseases: A systematic review.
Perlin CM; Longo L; Keingeski MB; Picon RV; Álvares-da-Silva MR
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37463798
[TBL] [Abstract][Full Text] [Related]
16. Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease.
Viebahn G; Hartmann P; Lang S; Demir M; Zhang X; Fouts DE; Stärkel P; Schnabl B
Gut Microbes; 2024; 16(1):2307586. PubMed ID: 38298161
[TBL] [Abstract][Full Text] [Related]
17. A Clinical Study Provides the First Direct Evidence That Interindividual Variations in Fecal β-Lactamase Activity Affect the Gut Mycobiota Dynamics in Response to β-Lactam Antibiotics.
Delavy M; Burdet C; Sertour N; Devente S; Docquier JD; Grall N; Volant S; Ghozlane A; Duval X; Mentré F; d'Enfert C; Bougnoux ME;
mBio; 2022 Dec; 13(6):e0288022. PubMed ID: 36448778
[TBL] [Abstract][Full Text] [Related]
18. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.
Lang S; Duan Y; Liu J; Torralba MG; Kuelbs C; Ventura-Cots M; Abraldes JG; Bosques-Padilla F; Verna EC; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross D; Lucey MR; Louvet A; Mathurin P; Garcia-Tsao G; Ho SB; Tu XM; Bataller R; Stärkel P; Fouts DE; Schnabl B
Hepatology; 2020 Feb; 71(2):522-538. PubMed ID: 31228214
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of
Mohamed N; Litlekalsøy J; Ahmed IA; Martinsen EMH; Furriol J; Javier-Lopez R; Elsheikh M; Gaafar NM; Morgado L; Mundra S; Johannessen AC; Osman TA; Nginamau ES; Suleiman A; Costea DE
Front Cell Infect Microbiol; 2021; 11():673465. PubMed ID: 34712619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
